Mastering Aetna Prior Authorization in New York

Aetna's Footprint and Regulatory Landscape in New York

Aetna maintains a significant presence across New York's healthcare market, serving commercial members, Medicare Advantage beneficiaries, and participants in Medicaid managed care plans (Aetna Better Health). Operations in New York are shaped by state-specific Medicaid managed care requirements, commercial payer footprints, and state-level prior authorization mandates, which influence turnaround times and appeals processes. Klivira's platform is designed to adapt to these varied state and payer-specific requirements.

Aetna Prior Authorization Submission Channels for New York Providers

Aetna's prior authorization submission channels vary by benefit category and are consistent for New York providers. Medical benefit precertification requests for commercial and Medicare Advantage plans primarily route through the Availity provider portal. For pharmacy benefit PA, administered by CVS Caremark, submissions typically route through CoverMyMeds or Surescripts ePA for retail, and CVS Caremark's direct provider portal for mail-order. Aetna also supports X12 278 transactions via clearinghouses for specific medical procedure categories, including inpatient admission notifications, which are subject to state regulations on notification windows.

Accessing Aetna Medical Necessity Criteria and Policy in New York

Aetna's medical necessity criteria are published as Clinical Policy Bulletins (CPBs) within the public Aetna CPB library. These CPBs are versioned, dated, and structured by topic, providing the canonical identifier for policy citations. For New York providers, understanding the specific CPB applicable to a service or drug is crucial for demonstrating medical necessity. Aetna discloses whether a CPB relies on internally developed criteria or references external sources, such as MCG or NCCN compendiums.

New York State Regulations and Aetna PA Turnaround Times

Prior authorization turnaround times for Aetna in New York are governed by a combination of state insurance regulations, payer-published service-level targets, and accreditation standards. Commercial PA timeframes are dictated by New York's state insurance regulations. Additionally, Aetna's Utilization Management operations are subject to NCQA UM accreditation standards, which set decision-timeframe norms. For Aetna's Medicare Advantage and Medicaid managed care lines (Aetna Better Health), CMS-0057-F mandates 72-hour decisions for standard PA and 24-hour for expedited PA, with phased compliance timelines impacting electronic PA API conformance by 2027.

Electronic Prior Authorization (ePA) with Aetna in New York

Aetna actively engages in electronic prior authorization initiatives. For pharmacy benefits, ePA is facilitated through established partnerships with CoverMyMeds and Surescripts. While Aetna participates in HL7 connectathons related to Da Vinci PAS, CRD, and DTR, the production conformance status for medical-benefit ePA through these standards requires verification. Klivira monitors these developments to ensure our platform aligns with the latest electronic submission capabilities, reducing manual effort for New York practices.

Key Considerations for Aetna Prior Authorization in New York

• Verify benefit category (medical vs. pharmacy) to determine correct submission channel for New York patients.
• Reference specific Aetna Clinical Policy Bulletins (CPBs) by number and review date for medical necessity documentation.
• Adhere to New York state-mandated PA timeframes and Aetna's published service-level targets.
• Understand the impact of CMS-0057-F on Aetna's Medicare Advantage and Aetna Better Health (Medicaid managed care) plans.
• Leverage electronic submission where available, including Availity for medical and CoverMyMeds/Surescripts for pharmacy PA.
• Be prepared for common denial categories such as medical necessity, insufficient documentation, or step therapy requirements.